Chemomab Therapeutics Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $13.8M
Liabilities Breakdown FY2025
Total Liabilities: $1.5M
Asset Breakdown
Total Assets: $13.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.6M | 54.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $176.0K | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $6.1M | 44.0% |
Liabilities Breakdown
Total Liabilities: $1.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $485.0K | 32.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $993.0K | 67.2% |